SEC Info - Ciba Specialty Chemicals Holding Inc/FI, et al. - ‘SC 13D/A’ on 3/18/97 re: 3D Systems Corp

SEC Info℠

Home

Help

Please Sign In

Ciba Specialty Chemicals Holding Inc/FI, et al. – ‘SC 13D/A’ on 3/18/97 re: 3D Systems Corp

As of: Tuesday, 3/18/97 · Accession #: 950157-97-202 · File #: 5-50669

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/18/97  Ciba Specialty Chemicals … Inc/FI SC 13D/A               1:26K  3D Systems Corp                   Cravath Swaine & … 01/FA
          Ciba Specialty Chemicals Canada Inc.
          Ciba Specialty Chemicals Holding Inc

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment No. 11 to Schedule 13D                      14     52K

Document Table of Contents

Page	(sequential)	\|	(alphabetic)	Top
			Alternative Formats (Word, et al.) Contracts, Arrangements, Understandings or Relationships with respect to Securities of the Issuer Identity and Background Interest in Securities of the Issuer Material to be Filed as Exhibits Purpose of Transaction Security and Issuer Source and Amount of Funds or other Consideration
1	1st Page - Filing Submission
4	Item 1. Security and Issuer
"	Item 2. Identity and Background
5	Item 3. Source and Amount of Funds or other Consideration
"	Item 4. Purpose of Transaction
"	Item 5. Interest in Securities of the Issuer
6	Item 6. Contracts, Arrangements, Understandings or Relationships with respect to Securities of the Issuer
7	Item 7. Material to be Filed as Exhibits

SC 13D/A 1st Page of 14 TOC ↑Top Previous Next ↓Bottom Just 1st
 
SECURITIES AND EXCHANGE COMMISSION        
Washington, D.C. 20549        

SCHEDULE 13D        

Under the Securities Exchange Act of 1934       
(Amendment No. 11)*       

3D Systems Corporation        
(Name of Issuer)        

Common Stock, Par Value $0.01 Per Share       
(Title of Class of Securities)        

885 54E 10 4        
(CUSIP Number)        

John Lynch        
Ciba Specialty Chemicals Canada Inc.        
7030 Century Avenue       
Mississauga, Ontario, Canada L5N 2V8        
(905) 812-6145        
(Name, Address and Telephone Number of Persons Authorized       
to Receive Notices and Communications)        

With copies to:       

    Peter Rupprecht                          Philip A. Gelston, Esq.
Ciba Specialty Chemicals Holding Inc.              Cravath, Swaine & Moore      
Klybeckstrasse 141                             Worldwide Plaza
   CH-4002, Basel                              825 Eighth Avenue
        Switzerland                           New York, New York 10019
   41-61-696-3415                               (212) 474-1000

March 13, 1997        
(Date of Event which Requires Filing of this Statement)       

If the filing person has previously filed a statement on Schedule 13G to        
report the acquisition which is the subject of this Schedule 13D, and is        
filing this schedule because of Rule 13d-1(b)(3) or (4), check the              
following box o.                                                                

Note: Six copies of this statement, including all exhibits, should be           
filed with the Commission. See Rule 13d-1(a) for other parties to whom          
copies are to be sent.                                                          

* The remainder of this cover page shall be filled out for a reporting          
person's initial filing on this form with respect to the subject class          
of securities, and for any subsequent amendment containing information          
which would alter disclosures provided in a prior cover page.                   

The information required on the remainder of this cover page shall not          
be deemed to be "filed" for the purpose of Section 18 of the Securities         
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of         
that section of the Act but shall be subject to all other provisions of         
the Act (however, see the Notes).                                               

(Continued on following page(s))        

Page 1 of 14        

SC 13D/A 2nd Page of 14 TOC 1st Previous Next ↓Bottom Just 2nd
      SCHEDULE 13D

CUSIP No. 88554E 10 4                                                           

1    NAME OF REPORTING PERSON                                               
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON                 

Ciba Specialty Chemicals Canada Inc.                              
(previously known as 1726 Holdings Canada Inc.)                   

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP          (a) [ ]      
                                                         (b) [X]

3    SEC USE ONLY                                                           

4    SOURCE OF FUNDS                                                        
WC                                                                

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED               
PURSUANT TO ITEMS 2(d) OR 2(e)                                 [ ]

6    CITIZENSHIP OR PLACE OF ORGANIZATION                                   
Switzerland                                                       

NUMBER OF               7   SOLE VOTING POWER           
SHARES                    1,725,366                 
BENEFICIALLY              8   SHARED VOTING POWER           
OWNED BY EACH                 (See Response to Item 5.)     
REPORTING               9   SOLE DISPOSITIVE POWER      
PERSON WITH                  1,725,366                    
                   10   SHARED DISPOSITIVE POWER
                         (See Response to Item 5.)

11    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON            
(See Response to Item 5.)                                         

12    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES                  
CERTAIN SHARES                                                 [X]

13    PERCENT OF CLASS REPRESENTED                                            
BY AMOUNT IN ROW (11)                                             
(See response to Item 5.)                                         

14    TYPE OF REPORTING PERSON*                                               
HC, CO                                                            

            Page 2 of 14

SC 13D/A 3rd Page of 14 TOC 1st Previous Next ↓Bottom Just 3rd
      SCHEDULE 13D

CUSIP No. 88554E 10 4                                                           

1    NAME OF REPORTING PERSON                                               
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON                 

Ciba Specialty Chemicals Holding Inc.                             

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP          (a) [ ]      
                                                         (b) [X]

3    SEC USE ONLY                                                           

4    SOURCE OF FUNDS                                                        
WC                                                                

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED               
PURSUANT TO ITEMS 2(d) OR 2(e)                                 [ ]

6    CITIZENSHIP OR PLACE OF ORGANIZATION                                   
Switzerland                                                       

NUMBER OF               7   SOLE VOTING POWER           
SHARES                    -0-                       
BENEFICIALLY              8   SHARED VOTING POWER           
OWNED BY EACH                 (See Response to Item 5.)     
REPORTING               9   SOLE DISPOSITIVE POWER      
PERSON WITH                  -0-                          
                   10   SHARED DISPOSITIVE POWER
                         (See Response to Item 5.)

11    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON            
(See Response to Item 5.)                                         

12    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES                  
CERTAIN SHARES                                                 [X]

13    PERCENT OF CLASS REPRESENTED                                            
BY AMOUNT IN ROW (11)                                             
(See response to Item 5.)                                         

14    TYPE OF REPORTING PERSON*                                               
HC, CO                                                            

            Page 3 of 14

SC 13D/A 4th Page of 14 TOC 1st Previous Next ↓Bottom Just 4th
Introduction        

On July 21, 1988, Ciba-Geigy Limited ("Ciba"), 1726 Holdings
Ltd., which was subsequently renamed 1726 Holdings Canada Inc. ("1726"),        
and certain affiliated entities filed a statement on Schedule 13D (the          
"Statement") in connection with an investment by Ciba, 1726 and such            
affiliates in the common stock of 3-D Systems, Inc. ("3-D Canada") (the         
predecessor of 3D Systems Corporation). On June 26, 1995, Ciba and 1726         
filed Amendment No. 10 to the Statement, which prior to the date hereof,        
was the final amendment to the Statement. In connection with the merger         
of Ciba and Sandoz Ltd. ("Sandoz"), the shareholders of Ciba and Sandoz         
determined that it was in their best interests to spin off the specialty        
chemicals businesses of Ciba and its affiliates as a separate company.          
Ciba Specialty Chemicals Holding Inc. ("SCH") was formed to hold the            
worldwide specialty chemicals businesses of Ciba and Ciba's affiliates.         
The closing of the spin-off transaction became effective upon the               
opening of business on March 13, 1997.                                          

Accordingly, SCH and Ciba Specialty Chemicals Canada Inc,   
formerly 1726 ("SC Canada" and, together with SCH, the "Reporting               
Persons"), hereby amend, restate and supplement the Statement formerly          
filed by Ciba and 1726.                                                         

Item 1.  Security and Issuer.                                                   

This amendment to a statement on Schedule 13D relates to the
common stock, $0.001 par value per share (the "Common Stock"), of 3D            
Systems Corporation, a Delaware corporation (the "Issuer"). The address         
of the principal executive offices of the Issuer is 26081 Avenue Hall,          
Valencia, CA 91355.                                                             

Item 2.  Identity and Background.                                               

(a), (b), (c) and (f) SCH, a corporation organized under the
laws of Switzerland, has its principal executive offices and principal          
business offices at Klybeckstrasse 141, CH-4002, Basel, Switzerland. SCH        
is a holding company; the principal business of its subsidiaries and            
investments is researching, developing, manufacturing, marketing,               
distributing and selling specialty chemicals worldwide.                         

SC Canada, a corporation organized under the federal laws of
Canada, has as its principal business manufacturing, marketing,                 
distributing and selling specialty chemicals in Canada. The principal           
executive offices and principal business offices of SC Canada are located       
at 7030 Century Avenue, Mississauga, Ontario, L5N 2V8. SC Canada is a           
wholly owned subsidiary of SCH.                                                 

The name, business address, present principal occupation or 
employment and citizenship of the executive officers and members of the         
Board of Directors of each of the Reporting Persons is set forth on             
Schedule 1 hereto and is incorporated herein by reference.                      

(d) and (e) Other than the matters described in Schedule 2, 
none of the Reporting Persons nor, to the best knowledge of each of             
them, any of the persons listed on Schedule 1 hereto with respect to            
each such Reporting Person during the last five years, (i) has been             
convicted in a criminal proceeding (excluding traffic violations or             
similar misdemeanors) or (ii) was a party to a civil proceeding of a            
judicial or administrative body of competent jurisdiction and as a              
result of such proceeding was or is subject to a judgment, decree or            
final order enjoining future violations of, or prohibiting or mandating         

Page 4 of 14        

SC 13D/A 5th Page of 14 TOC 1st Previous Next ↓Bottom Just 5th
activities subject to, Federal or state securities laws or finding any          
violation with respect to such laws.                                            

Item 3.  Source and Amount of Funds or other Consideration.                     

  In July of 1988, 1726 acquired approximately 93% of the common
stock of Lionheart Capital Corp.("Lionheart"), which at that time               
beneficially owned 5,378,301 shares of the common stock of 3-D Canada.          
On August 30, 1989, Lionheart sold 1,500 shares of such common stock. In        
April of 1989, 1726 purchased an additional 1,071,429 shares of the             
common stock of 3-D Canada. On June 29, 1992, Lionheart and 1726                
exercised rights to purchase an additional 2,689,655 and 535,715 shares         
of common stock of 3-D Canada, respectively. The funds used to make such        
purchases were loaned to 1726 by Ciba. The funds used to make the loans         
were obtained from Ciba's working capital. On December 1, 1993,                 
Lionheart dissolved with the result that 1726 became the direct                 
beneficial owner of all shares of common stock of 3-D Canada previously         
owned by Lionheart.                                                             

On May 24, 1995, the Issuer completed a reverse split, on a 
one-for-three basis, of the Common Stock, with the result that the              
9,676,100 shares of Common Stock beneficially owned by the Reporting            
Persons become 3,225,366 shares. On June 26, 1995, 1726 sold 1,500,000          
shares of Common Stock as part of a firm commitment underwritten public         
offering.                                                                       

Item 4.  Purpose of Transaction.                                                

 The purpose of the original transaction was to obtain control
of Lionheart and thereby to seek representation on the board of                 
directors of Lionheart and its subsidiaries, including the Issuer, so as        
to influence the future strategic direction of such entities.                   

Item 5.  Interest in Securities of the Issuer.                                  

(a) As of the date hereof, the aggregate number of shares of
Common Stock and the percentage of the outstanding Shares beneficially          
owned by each Reporting Person are as follows:                                  

Reporting Person           Shares Beneficially        Percentage of Shares      
                       Owned                      Beneficially Owned<F1>

SC Canada                  1,725,366                  15.2%                     
SCH                        1,725,366                  15.2%                     

By virtue of the Shareholders Agreement (as defined below), 
SCH and SC Canada may be deemed to constitute a "group" (within the             
meaning of the 1934 Act) with the Founders (as defined below). If so,           
SCH and SC Canada would be deemed part of a group beneficially owning           
2,417,241 shares of Common Stock (representing approximately 21.3% of           

--------------------                                                            
[FN]                                                                            
<F1>                                                                            
1 Determined pursuant to Rule 13d-3(d)(1) under the Securities                  
Exchange Act of 1934, as amended (the "1934 Act"), and based on the             
11,342,826 shares of Common Stock outstanding on October 31, 1996, as           
disclosed in the Issuer's Form 10-Q for the quarter ended September 27,         
1996.                                                                           

Page 5 of 14        

SC 13D/A 6th Page of 14 TOC 1st Previous Next ↓Bottom Just 6th
the outstanding shares of Common Stock).<F2> Except as set forth in Item 4      
of this Schedule 13D, the Reporting Persons disclaim beneficial                 
ownership of all shares of Common Stock which are deemed to be                  
beneficially owned by them as a result of membership in a group with one        
or more of the Founders.                                                        

  (b) SC Canada has sole voting power and sole dispositive power
with respect to 1,725,366 shares of Common Stock. SCH, by virtue of its         
beneficial ownership of all outstanding shares of common stock of SC            
Canada, may be deemed to have shared voting power and shared dispositive        
power over the 1,725,366 shares of Common Stock deemed to be                    
beneficially owned by SC Canada.                                                

To the best knowledge of each of the Reporting Persons, none
of the persons listed on Schedule 1 hereto with respect to such                 
Reporting Person is the beneficial owner of any shares of Common Stock.         

(c) Neither the Reporting Persons nor, to the best knowledge
of each of the Reporting Persons, any of the persons listed on Schedule         
1 with respect to each such Reporting Person has engaged in any                 
transaction in the Common Stock in the past 60 days.                            

(d) None.                                                   

(e) Not applicable.                                         

Item 6.  Contracts, Arrangements, Understandings or Relationships with          
respect to Securities of the Issuer.                                            

 In April 1991, Lionheart and 1726 entered into a Shareholders
Agreement (the "Shareholders Agreement") dated as of April 10, 1991,            
among 3-D Canada, 1726, Lionheart and certain individual shareholders           
(such shareholders, the "Founders"). The Reporting Persons, as                  
successors to Lionheart and 1726, are subject to the Shareholders               
Agreement. The Shareholders Agreement provides, among other things, (i)         
that the Board of Directors of the Issuer shall consist of five members         
and (ii) that the slate of nominees to the Board of Directors of the            
Issuer recommended by the Board of Directors or management of the Issuer        
to its stockholders shall consist of two persons designated by SC               
Canada, two persons designated by the Founders and one person designated        
by the first four directors. The foregoing provisions of the                    
Shareholders Agreement may be terminated (i) by SC Canada at any time           
after the Founders cease to have, in the aggregate, beneficial ownership        
of at least 10% of the outstanding voting securities of the Issuer or           
(ii) by the Founders at any time after the Reporting Persons and all of         
their affiliates cease to have, in the aggregate, beneficial ownership          
of at least 10% of the outstanding voting securities of the Issuer. The         
Shareholders Agreement also provides for certain rights of first refusal        
between the Founders, on the one hand, and the Reporting Persons and            
their affiliates, on the other hand, with respect to the direct or              
indirect sales of shares of Common Stock.                                       

A copy of the form of Shareholders Agreement was attached as
an exhibit to the Exchange Agreement dated as of July 23, 1990, which,          

--------                                                                        
[FN]                                                                            
<F2> Determined pursuant to Rule 13d-3(d)(1) under the 1934 Act                 
and based on the 11,342,826 shares outstanding on October 31, 1996, as          
disclosed in Issuer's Form 10-Q for the quarter ended September 27,             
1996, and the beneficial ownership of 691,875 shares of Common Stock by         
the Founders on March 31, 1996, as disclosed in the Issuer's proxy              
statement for its 1996 annual meeting.                                          

Page 6 of 14        

SC 13D/A 7th Page of 14 TOC 1st Previous Next ↓Bottom Just 7th
in turn, was filed as Exhibit 1 to Amendment No. 5 to the Schedule 13D,         
which Exhibit is incorporated herein by reference.                              

  Except for the Shareholders Agreement, there are no contracts,
arrangements, understandings or relationships (legal or otherwise) among        
the Reporting Persons or, to the best knowledge of each of the Reporting        
Persons, any of the persons listed on Schedule 1 hereto with respect to         
each such Reporting Person, with respect to any securities of the               
Issuer, including but not limited to transfer or voting of any of the           
securities, finder's fees, joint ventures, loan or option arrangements,         
puts or calls, guarantees of profits, divisions of profits or loss, or          
the giving or withholding of proxies.                                           

Item 7.   Material to be Filed as Exhibits.                                     

(1)       Agreement between Ciba-Geigy Limited, Ciba-Geigy Investments          
Ltd., Ciba-Geigy Ltd. and 1726 Holdings Ltd. with respect to
 the joint filing of the Statement 13D and amendments thereto.

(2)       Agreement dated as of June 2, 1988, between Harry C. Moll and         
Spectra-Physics.                                            

(3)       Loan Agreement dated as of July 12, 1988, between Ciba-Geigy          
Canada and 1726 Holdings Ltd.                               

(4)       Joint Filing Consent dated as of March 28, 1989, of Lionheart         
Capital Corporation.                                        

(5)       Exchange Agreement dated March 28, 1989, among 3-D Systems            
Inc., 3D Systems, Inc., Lionheart Capital Corp. and Raymond 
Freed, Charles Hull, Bethany Griffiths, Virginia Hiramatsu, 
Paul B. Warren and Edwin J. Kaftal.                         

(6)       Subscription Agreement dated as of April 18, 1989, between 3-D        
Systems Inc. and 1726 Holdings Ltd.                         

(7)       Exchange Agreement dated March 28, 1989, among 3-D Systems            
Inc., 3D Systems, Inc., Lionheart Capital Corp. and Raymond 
Freed, Charles Hull, Bethany Griffiths, Virginia Hiramatsu, 
Paul B. Warren and Edwin J. Kaftal.                         

(8)       Stand-Still Agreement between Ciba-Geigy Limited, 3-D Systems,        
Inc. and Raymond S. Freed, individually and as Founders'    
Agent.                                                      

(9)       Termination Agreement dated as of April 5, 1991, between              
Ciba-Geigy Limited, 3-D Systems, Inc. and Raymond S. Freed, 
individually and as Founders' Agent.                        

(10)      Underwriting Agreement dated as of June 21, 1995, by and among        
 Raymond James & Associates and Southcoast Capital Corporation
as Representatives of the Several Underwriters, 3D Systems  
Corporation, 1726 Holdings Canada Inc. and Silicon Valley   
Bank.                                                       

(11)      Registration and Indemnification Agreement dated as of June           
21, 1995 by and between 3D Systems Corporation and 1726     
Holdings Canada Inc.                                        

Page 7 of 14        

SC 13D/A 8th Page of 14 TOC 1st Previous Next ↓Bottom Just 8th
SIGNATURE       

 After reasonable inquiry and to the best of the knowledge and
belief of the undersigned, the undersigned certifies that the                   
information set forth in this statement is true, complete and correct.          

Dated:  March 17, 1997                                                          

                                   CIBA SPECIALTY CHEMICALS CANADA
         INC.,

                           by   /s/ JOHN LYNCH
                                  ----------------
                                   Name:  John Lynch
                                             Title: Secretary, Treasurer
                                                   and Chief Financial
                                       Officer

Page 8 of 14        

SC 13D/A 9th Page of 14 TOC 1st Previous Next ↓Bottom Just 9th
       EXHIBIT INDEX

Exhibit                                                                         
Number          Description                                       Page No.      

(1)             Agreement between Ciba-Geigy Limited, Ciba-       *             
Geigy Investments Ltd., Ciba-Geigy Ltd. and     
1726 Holdings Ltd. with respect to the joint    
filing of the Statement 13D and amendments      
thereto.                                        

(2)             Agreement dated as of June 2, 1988, between       *             
Harry C. Moll and Spectra-Physics.              

(3)             Loan Agreement dated as of July 12, 1988,         *             
between Ciba-Geigy Canada and 1726 Holdings     
Ltd.                                            
(4)             Joint Filing Consent dated as of March 28,        *             
1989, of Lionheart Capital Corporation.         

(5)             Exchange Agreement dated March 28, 1989, among    *             
3-D Systems Inc., 3D Systems, Inc., Lionheart   
Capital Corp. and Raymond Freed, Charles Hull,  
Bethany Griffiths, Virginia Hiramatsu, Paul B.  
Warren and Edwin J. Kaftal.                     

(6)             Subscription Agreement dated as of April 18,      *             
1989, between 3-D Systems Inc. and 1726         
Holdings Ltd.                                   

(7)             Exchange Agreement dated March 28, 1989, among    *             
3-D Systems Inc., 3D Systems, Inc., Lionheart   
Capital Corp. and Raymond Freed, Charles Hull,  
Bethany Griffiths, Virginia Hiramatsu, Paul B.  
Warren and Edwin J. Kaftal.                     

(8)             Stand-Still Agreement between Ciba-Geigy          *             
Limited, 3-D Systems, Inc. and Raymond S. Freed,
individually and as Founders' Agent.            

(9)             Termination Agreement dated as of April 5,        *             
1991, between Ciba-Geigy Limited, 3-D Systems,  
Inc. and Raymond S. Freed, individually and as  
Founders' Agent.                                

(10)            Underwriting Agreement dated as of June 21,       *             
1995, by and among Raymond James & Associates   
and Southcoast Capital Corporation as           
Representatives of the Several Underwriters, 3D 
Systems Corporation, 1726 Holdings Canada Inc.  
and Silicon Valley Bank.                        

(11)            Registration and Indemnification Agreement        *             
dated as of June 21, 1995 by and between 3D     
Systems Corporation and 1726 Holdings Canada    
Inc.                                            

*       Previously filed                                                        

            Page 9 of 14

SC 13D/A 10th Page of 14 TOC 1st Previous Next ↓Bottom Just 10th
                                                      SCHEDULE 1

Members of the Board of Directors and Executive Officers of Ciba                
Specialty Chemicals Canada Inc. ("SC Canada")                                   

The name, address, citizenship and present principal        
occupation or employment of each of the directors and executive officers        
of SC Canada are set forth below. Unless otherwise indicated below, each        
occupation set forth opposite an individual's name refers to employment         
with SC Canada.                                                                 

Name, Function &                        Present Principal Occupation or         
Business Address         Citizenship    Employment                              
----------------         -----------    ----------                              

John Rankin,             Canada         President and Chief Executive           
Director                                Officer President, Additives            
7030 Century Avenue                     Division                                
Mississauga, Ontario                                                            
Canada                                                                          
L5N 2V8                                                                         

John Lynch,              Canada         Vice President and Chief Financial      
Director                                Officer                                 
7030 Century Avenue                                                             
Mississauga, Ontario                                                            
Canada                                                                          
L5N 2V8                                                                         

Joseph Babiak,           Canada         Vice President                          
Director                                President, Pigments Division            
2270 Argentia Road                                                              
Mississauga, Ontario                                                            
Canada                                                                          
L5N 6A6                                                                         

Harold E. Kinne,         United         Vice President - Ciba Specialty         
Director                 States         Chemicals Corporation (US)              
540 White Plains Road                   President, Additives Division (US)      
P.O. Box 2005                                                                   
Tarrytown, NY                                                                   
10591-2005                                                                      

Stanley Sherman,         United         Director, President and Chief           
Director                 States         Executive Officer - Ciba Specialty      
560 White Plains Road                   Chemicals Corporation (US)              
P.0. Box 2005                                                                   
Tarrytown, NY                                                                   
10591-2005                                                                      

Page 10 of 14       

SC 13D/A 11th Page of 14 TOC 1st Previous Next ↓Bottom Just 11th
Members of the Board of Directors and Executive Officers of Ciba                
Specialty Chemicals Holding Inc. ("SCH")                                        

The name, address, citizenship and present principal        
occupation or employment of each of the directors and executive officers        
of SCH are set forth below. Unless otherwise indicated below, each              
occupation set forth opposite an individual's name refers to employment         
with SCH.                                                                       

Name, Function &                        Present Principal Occupation or         
Business Address         Citizenship    Employment                              
----------------         -----------    ----------                              

Rolf A. Meyer            Switzerland    Member of the boards                    
Chairman and Delegate                   of directors of                         
of the Board                            Union Bank of                           
c/o Ciba Specialty                      Switzerland, Siber                      
Chemicals Holding Inc.                  Hegner and the Swiss                    
Klybeckstrasse 141                      Exchange.                               
CH-4002                                                                         
Basle, Switzerland                                                              

Theodor M. Tschopp       Switzerland    Member of the Board                     
Vice Chairman of the                    and Chief Executive                     
Board                                   Officer of                              
c/o Ciba Specialty                      Alusuisse-Lonza,                        
Chemicals Holding Inc.                  member of the board                     
Klybeckstrasse 141                      of Credit Suisse Group                  
CH-4002                                                                         
Basle, Switzerland                                                              

Erwin A. Heri            Switzerland    Member of the executive                 
Director                                committee of Winterthur                 
c/o Ciba Specialty                      Versicherungen;                         
Chemicals Holding Inc.                  member of the boards of                 
Klybeckstrasse 141                      directors of Intershop,                 
CH-4002                                 Commerzbank (Schweiz)                   
Basle, Switzerland                                                              

Gertrud Hohler            Germany       Management consultant,                  
Director                                publicist                               
c/o Ciba Specialty                                                              
Chemicals Holding Inc.                                                          
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

Jean-Marie Pierre         France        Professor of Chemistry and              
Lehn, Director                          Physics, College de                     
c/o Ciba Specialty                      France, Nobel prize winner              
Chemicals Holding Inc.                                                          
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

Page 11 of 14       

SC 13D/A 12th Page of 14 TOC 1st Previous Next ↓Bottom Just 12th
Peter Littmann            Germany        Chairman of the                        
Director                                 managing board of                      
c/o Ciba Specialty                       Hugo Boss, member of                   
Chemicals Holding Inc.                   the supervisory                        
Klybeckstrasse 141                       board of Mercedes-                     
CH-4002                                  Benz                                   
Basle, Switzerland                                                              

Armin Meyer               Switzerland    Member of the                          
Director                                 executive committee                    
c/o Ciba Specialty                       of ABB Asea Brown                      
Chemicals Holding Inc.                   Boveri                                 
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

Hermann Vodicka           Switzerland    Chief Executive                        
Director                                 Officer                                
c/o Ciba Specialty                                                              
Chemicals Holding Inc.                                                          
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

Michael Jacobi            Switzerland    Chief Financial                        
c/o Ciba Specialty                       Officer                                
Chemicals Holding Inc.                                                          
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

Reinhard Neubeck          Germany        Head of Additives                      
c/o Ciba Specialty                       Division                               
Chemicals Holding Inc.                                                          
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

Martin Riediker           Switzerland    Head of Consumer                       
c/o Ciba Specialty                       Care Chemicals                         
Chemicals Holding Inc.                   Division                               
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

Werner Dittes             Switzerland    Head of Performance                    
c/o Ciba Specialty                       Polymers Division                      
Chemicals Holding Inc.                                                          
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

Peter Schutz              Switzerland    Head of Pigments                       
c/o Ciba Specialty                       Division                               
Chemicals Holding Inc.                                                          
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

Jean-Luc Schwitzguebel    Switzerland    Head of Textile Dyes                   
c/o Ciba Specialty                       Division                               
Chemicals Holding Inc.                                                          
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

Franz Gerny               Switzerland     Head of                               
c/o Ciba Specialty                        International                         
Chemicals Holding Inc.                    Coordination and                      
Klybeckstrasse 141                        Human Resources                       
CH-4002                                                                         
Basle, Switzerland                                                              

Page 12 of 14       

SC 13D/A 13th Page of 14 TOC 1st Previous Next ↓Bottom Just 13th
John Cheesmond            United          Head of Corporate                     
c/o Ciba Specialty        Kingdom         Strategy and                          
Chemicals Holding Inc.                    Business Development                  
Klybeckstrasse 141                                                              
CH-4002                                                                         
Basle, Switzerland                                                              

             Page 13 of 14

SC 13D/A Last Page of 14 TOC 1st Previous Next ↓Bottom Just 14th
                                                      SCHEDULE 2

Although none of the Reporting Persons nor, to the best knowledge     
of each of them, any of the persons listed on Schedule 1 hereto with            
respect to each such Reporting Person was involved during the last five         
years with any activity which would be required to be disclosed pursuant        
to Item 2(d) or (e), Ciba-Geigy Corporation ("CGC"), a subsidiary of            
Ciba, the predecessor to SCH, would be required to disclose the                 
following:                                                                      

On February 28, 1992, CGC and two employees from its Toms River       
plant pleaded guilty in Superior Court, Law Division, Mercer County, New        
Jersey to one count of unintentional illegal disposal of pollutants in a        
double-lined landfill. Judgment of conviction was entered on March 23,          
1992. As part of the settlement agreement, CGC paid a criminal fine of          
$3.5 million, civil penalties of $5.5 million and administrative costs          
of $2.35 million. At the same time, it made a contribution to the State         
of New Jersey of $2.5 million for environmental purposes.                       

On August 14, 1992, CGC pleaded no contest in Louisiana State         
Court, 18th Judicial District, to fifteen misdemeanor counts arising            
from falsification of certain back-up quality control data relating to          
water discharge permits at its St. Gabriel plant and paid a $250,000            
fine. At the same time, it made two contributions of $50,000 each to the        
Sheriff's offices of Iberville Parish and West Baton Rouge Parish.              

In 1992, CGC pleaded guilty to an Environmental Control Complaint     
and Summons resulting from an odor emission at its Newport, Delaware            
plant site. The matter was under the jurisdiction of the Delaware               
Justice of the Peace Court, Newport, Delaware. A fine of $598.50 was            
paid.                                                                           

Page 14 of 14

SC 13D/A	1st Page of 14	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

SC 13D/A	2nd Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 2nd

SC 13D/A	3rd Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 3rd

SC 13D/A	4th Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 4th

SC 13D/A	5th Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 5th

SC 13D/A	6th Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 6th

SC 13D/A	7th Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 7th

SC 13D/A	8th Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 8th

SC 13D/A	9th Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 9th

SC 13D/A	10th Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 10th

SC 13D/A	11th Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 11th

SC 13D/A	12th Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 12th

SC 13D/A	13th Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 13th

SC 13D/A	Last Page of 14	TOC	1st	Previous	Next	↓Bottom	Just 14th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘SC 13D/A’ Filing	Date	First	Last	Other Filings

Filed on:	3/18/97			SC 13D/A
	3/17/97	8
	3/13/97	1	4
	10/31/96	5	6
	9/27/96	5	6	10-Q
	3/31/96	6
	6/26/95	4	5
	6/21/95	7	9
	5/24/95	5
	12/1/93	5
	8/14/92	14
	6/29/92	5
	3/23/92	14
	2/28/92	14
				List all Filings

↑Top

Filing Submission 0000950157-97-000202 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Ciba Specialty Chemicals Holding Inc/FI, et al. – ‘SC 13D/A’ on 3/18/97 re: 3D Systems Corp

As of: Tuesday, 3/18/97 · Accession #: 950157-97-202 · File #: 5-50669

Previous ‘SC 13D’: ‘SC 13D/A’ on 3/18/97 · Next: ‘SC 13D/A’ on 5/23/00 · Latest: ‘SC 13D/A’ on 12/20/00

Amendment to General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

Document Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents